Thanks to the development and widespread use of highly active antiretroviral therapy (ART) since the mid-1990s, the life expectancy of people living with the human immunodeficiency virus (HIV) has greatly increased. As a result, there is a growing population of older adults living with HIV.
There is a growing population of older adults living with HIV.
According to the U.S. Centers for Disease Control and Prevention (CDC), 59 percent of people living with HIV in the U.S. were 45 years or older in 2019. Around 24 percent were aged 45 to 54, and around 34 percent were 55 and older.
Advancements in HIV treatment have significantly narrowed the life expectancy gap between people living with HIV and the general population, especially among those who start treatment early and who are able to maintain high CD4 counts (levels of CD4 T cells). A 2023 study spanning from 1996 to 2019 showed that, for people with higher CD4 cell counts who were undergoing ART treatment, life expectancy was just a few years lower than that of the general public.
Key factors influencing life expectancy include CD4 count at treatment start, with higher CD4 levels linked to lower mortality risk (risk of death). Other risk factors that may affect a person’s life expectancy include:
Compared with the general population, people who have received an HIV diagnosis have an increased risk of developing certain comorbidities. A comorbidity is a disease or medical condition that occurs at the same time as another condition. As people age, they become more susceptible to age-related comorbidities that may reduce their quality of life. The following list highlights five types of health problems worth watching out for as you age with HIV.
Metabolic problems occur when the body is unable to break down and use proteins, fats, and carbohydrates. The prevalence of metabolic dysfunction that resembles metabolic syndrome is higher for people with HIV. Metabolic syndrome includes hypertriglyceridemia (high triglycerides, a type of fat, in the blood), low high-density lipoprotein cholesterol (the “good” type of cholesterol), and insulin resistance. These conditions predict an increased risk of cardiovascular disease, which is a term used to describe diseases that affect the heart or blood vessels.
One study looked at whether people aged 18 and older living with HIV had higher rates of comorbidities compared to people without HIV. The results showed that people with HIV were more likely to have chronic (long-term) conditions such as diabetes, high blood pressure, high cholesterol, and chronic kidney disease.
Stroke was also seen more often in people with HIV. However, the rates of myocardial infarction (heart attack) and coronary artery disease (buildup of plaque in the arteries supplying blood to the heart) were the same between the two groups.
Another study found similar results. Compared to those without HIV, people aged 50 or older with HIV were more likely to have chronic conditions such as diabetes, high blood pressure, stroke, lung diseases, and dementia. The researchers also noted a higher risk of cardiovascular disease.
Another chronic health condition, liver disease, is among the leading causes of non-AIDS-related death in people with HIV. Coinfection with hepatitis B and hepatitis C viruses (HBV and HCV) is common in people with HIV — particularly among those who acquired HIV while using injectable drugs. For example, 5 percent to 25 percent of those with HIV may be coinfected with HBV, and 30 percent may have HCV. When a person has both HIV and HBV or HCV, there is a faster progression to scarring and permanent damage of the liver, resulting in long-term liver disease and risk of liver cancer. However, better treatments for hepatitis C are improving the outlook for people who have both HIV and HCV.
Lymphoma (a type of cancer in the immune system) and cancers related to human papillomavirus (HPV) were also more likely to develop in people with HIV.
Types of cancers related to HPV — and the part of the body affected — include:
The incidence (number of new cases) of liver and lung cancers is also higher in people with HIV. The increased rate of lung cancers is largely explained by high rates of cigarette smoking.
Not only do age-related comorbid conditions occur more often in people with HIV than in people without HIV, but they also develop at younger ages.
Osteoporosis is commonly seen in older age. This condition occurs when the bones become weak, causing them to break easily. Osteoporosis is common in people with HIV. Some types of ART therapy may also increase the risk of osteoporosis. Older adults are at a higher risk of falls as well, which is especially dangerous when coupled with the increased risk of osteoporosis and fractures.
Osteoporosis is commonly seen in older age. Osteoporosis is also common in people with HIV.
Frailty, which is generally seen in the geriatric (older) population, commonly occurs at an earlier age in people with HIV. Symptoms include weakness, exhaustion, decreased physical activity, and weight loss. This condition is associated with negative health outcomes and multimorbidity (two or more co-occurring chronic conditions). Frail older adults are more likely to be admitted to the hospital and require long-term care.
Decreased mental function can also occur in the aging population, as well as in those with HIV. Individuals living with HIV-associated dementia, a severe form of dementia, show decreased attention and concentration, as well as slowed thinking and slow body movements. About one-third of people with HIV have at least a mild form of neurocognitive impairment.
Recent research shows that people living with HIV who haven’t received a COVID-19 vaccine may have a slightly higher risk of dying from the coronavirus, compared to people who don’t have HIV and haven’t been vaccinated. Vaccinations have proved to significantly reduce the risk of severe illness or death from COVID-19 for people living with HIV, especially when their immune system maintains a CD4 count above 350.
Age is the main risk factor for COVID-19-related deaths. Prior to the availability of vaccines, people 80 and higher faced a risk of death at least 20 times higher than those between 50 and 59 years old. Despite the significant protection COVID-19 vaccines offer, older adults who are fully vaccinated still face greater risks compared to their younger vaccinated counterparts.
Additionally, studies show that people with HIV as well as other health conditions may face a greater risk of severe illness or death from COVID-19. These conditions include higher body weight, diabetes, and hypertension (high blood pressure).
People living with HIV are at a higher risk of developing comorbidities due to a variety of factors, including:
Talk with your HIV care provider about preventing future comorbidities as you age with HIV. Continue taking your antiretroviral treatment, and keep your HIV controlled by having regular follow-up visits with your HIV care team.
Talk with your HIV care provider about preventing future comorbidities as you age with HIV.
On myHIVteam, the social network for people with HIV and their loved ones, more than 40,000 people come together to ask questions, give advice, and share their stories with others who understand life with HIV.
Are you an older adult living with HIV? Are you also living with a comorbidity such as heart disease or cancer? Share your experience in the comments below, or start a conversation by posting on your Activities page.
Get updates directly to your inbox.
Is Vaping (no Smoke Involved). Is This A Good Alternative To Smoking It
The Oldest Person Living With H I V What Age?
This Is Great Information Which I Can Identify With. I'm 77 And As I Age I Am Experiencing New Comorbidities.
Are People With HIV More Susceptible To Bladder Cancer Than Those Without HIV?
I’ve Had 2 Strokes Due To HIV Anybody Else Have Strokes Or Brain Bleeds
Become a member to get even more:
A myHIVteam Member
Good Article!
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.